Studies of HIV in Digestive Diseases Limited to Gastrointestinal Mucosal Immunology and Liver Diseases (R01- Clinical Trial Optional)

NIH Funding Announcements - Thu, 11/09/2017 - 12:46
Funding Opportunity RFA-DK-17-038 from the NIH Guide for Grants and Contracts. The goal of this FOA is to support innovative, basic and translational research in two areas, gastrointestinal (GI) mucosal immunology and liver disease. The emphasis for GI mucosal immunology is on elucidation of mechanisms whereby innate and adaptive immunity in the GI tract interacts with HIV infection in the presence or absence of antiretroviral therapy (ART) and contributes to HIV infection, persistence, disruption of GI homeostasis, and pathogenesis. The emphasis for liver disease is on pathophysiologic mechanisms of injury to the liver and the biliary system during HIV infection and epidemiological studies of liver diseases and disorders in HIV patients.
Categories: NIH-Funding

Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01) (Clinical Trial Required)

NIH Funding Announcements - Thu, 11/09/2017 - 12:31
Funding Opportunity RFA-HL-18-027 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications to enhance the pool of of highly trained investigators from diverse backgrounds underrepresented in research. It is targeted toward individuals whose basic, clinical, and translational research interests are grounded in the advanced methods and experimental approaches needed to solve problems related to cardiovascular, pulmonary, and hematologic diseases and sleep disorders in the general and health disparities populations. This FOA invites applications from Institutions with eligible faculty members to undertake special study and supervised research under a mentor who is an accomplished investigator in the research area proposed and has experience in developing independent investigators.
Categories: NIH-Funding

Notice of Clarification to PAR-15-304 Clinical and Translational Science Award (U54)

NIH Funding Announcements - Thu, 11/09/2017 - 11:25
Notice NOT-TR-18-006 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Notice of NHLBI Participation in PA-17-225 "Advancing the Science of Geriatric Palliative Care (R01)

NIH Funding Announcements - Thu, 11/09/2017 - 11:20
Notice NOT-HL-17-558 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

By: SaG

WriteEdit-Grant Questions Blog - Thu, 11/09/2017 - 08:31

Yes, In fact I have heard that awards are starting to be made. But, it will take awhile still before Notices of Award go out to PIs. Good luck!

Categories: NIH-Funding

By: trying

WriteEdit-Grant Questions Blog - Thu, 11/09/2017 - 01:03

Hi all,

I just received a score on my first (but probably also last, given eligibility) K99 application and got an impact score of 20 through NIMH. As most of us here, Im trying to find something to hold on to, at least until the summary statements become available and I can talk to my PO. Since NIMH doesn’t seem to publish a payline, I was wondering if there is any statistics on how scores translate into funding available for previous years. I have seen the success rate charts the NIH puts out, but since we don’t receive a percentile I cannot use these.

Many thanks for a great blog/community!

Categories: NIH-Funding

By: Celtics

WriteEdit-Grant Questions Blog - Wed, 11/08/2017 - 21:34

Is it possible to receive a new R01 award from NCI during continuing resolution (if R01 ranked 5 percentile and post-council review)?

Categories: NIH-Funding

By: lucien

WriteEdit-Grant Questions Blog - Wed, 11/08/2017 - 16:05

Dear Writedit,

I just received a score of 30 for an NLM EXPRESS RESEARCH R01 application. On the NLM website, it says, “applications with Impact scores 30 or better are the most likely to be considered for funding”. Assuming the 2018 funding situation is similar as 2017, how likely I will be considered for funding. Should I start preparing a re-submission?

Many thanks!

Categories: NIH-Funding

By: Kaden

WriteEdit-Grant Questions Blog - Wed, 11/08/2017 - 12:30

I received a score of 40 on my K01 application through NIDDK. It certainly looks like out of the funding range, but I keep hearing from colleagues about funded K01s in the upper 30s, through the same mechanism. While I have to wait for my summary statement and plan my resubmission, I was wondering if anyone has more insight into how K01s scores roughly translate to funding in NIDDK. Thnkas!

Categories: NIH-Funding

By: writedit

WriteEdit-Grant Questions Blog - Wed, 11/08/2017 - 12:06

Yes, this is common in either direction (animal first, to determine mechanism, then clinical pilot to observe whether mechanism documented in vivo is the same in humans, or as you suggest). If your budget creeps up too high (>$500K in any year), you will need PO permission in advance to submit (and a letter to this effect).

Categories: NIH-Funding

By: Abraham

WriteEdit-Grant Questions Blog - Wed, 11/08/2017 - 11:39

Dear write edit,

I have a question of R01 proposal. I want to observe a phenomenon in clinical study. And I hope to explain the phenomenon using an animal study. Can I put a clinical study and an animal study (on different specific aims) in a single R01 grant proposal?

Thank you!


Categories: NIH-Funding

Reducing Health Disparities Among Minority and Underserved Children (R21 Clinical Trial Optional)

NIH Funding Announcements - Wed, 11/08/2017 - 11:35
Funding Opportunity PA-18-169 from the NIH Guide for Grants and Contracts. This initiative encourages research that targets the reduction of health disparities among children. Investing in early childhood development is essential. Specific targeted areas of research include bio-behavioral studies that incorporate multiple factors that influence child health disparities such as biological (e.g., genetics, cellular, organ systems), lifestyle factors, environmental (e.g., physical and family environments) social (e.g., peers), economic, institutional, and cultural and family influences; studies that target the specific health promotion needs of children with a known health condition and/or disability; and studies that test, evaluate, translate, and disseminate health promotion prevention and interventions conducted in traditional and non -traditional settings
Categories: NIH-Funding

Chronic Condition Self-Management in Children and Adolescents (R21 Clinical Trial Optional)

NIH Funding Announcements - Wed, 11/08/2017 - 11:33
Funding Opportunity PA-18-168 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to encourage exploratory/developmental research to improve self-management and quality of life in children and adolescents with chronic conditions. Managing a chronic condition is an unremitting responsibility for children and their families. Children with a chronic condition and their families have a long-term responsibility for self-management. This FOA encourages research that takes into consideration various factors that influence self-management such as individual differences, biological and psychological factors, family/caregivers and sociocultural context, family-community dynamics, healthcare system factors, technological advances, and the role of the environment.
Categories: NIH-Funding